R.ChoiS
Flow cytometry results appeared to support this, indicating a redistribution of cells toward G1 and away from G2, which may reflect an acceleration of the cell cycle rather than arrest
Recommendations for use Bedoyecta tri is not intended for the intravenous route of administration, only for intramuscular administration
To date, few trials have reached their primary endpoints, and little evidence has promoted the approval of drug administration agencies or the use of the tested treatments in clinical practice
Future progress will require: (1) Parameter optimization studies: Systematic in vitro screening of DECLARATIONS Authors contribution Writing - original draft, investigation, conceptualization, and funding acquisition: Wang LY Writing - review and editing: Fan MY, Jiang XY, Bing KJ, Wang YJ, Zhang H Writing - review and editing, supervision: Wang KS, Huang YM Availability of data and materials Not applicable